- recruitingPHASE2, PHASE3
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
This study is testing a new treatment called hu14.18K322A, given with chemotherapy, for children and young people with a type of cancer called high-risk neuroblastoma. It aims to see if this combination treatment is safe and effective in fighting the cancer.
United States · Canada · Denmark - recruitingPHASE3
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
This study looks at new ways to treat high-risk neuroblastoma, a type of cancer, in children and young people. Researchers are testing different combinations of chemotherapy and radiation to find the most effective treatments to help patients live longer and healthier lives.
Australia · Austria · Belgium - active not recruitingPHASE2
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
This study looks at new ways to treat neuroblastoma that has come back or isn't responding to usual treatments. It tests if adding a drug called eflornithine to other medicines helps children with this type of cancer.
United States · Australia · Canada